U.S Imaging CRO Market Size, Share, By Services Offered (Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others), By Imaging Modality (Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others), By Application (Oncology, Cardiovascular, Neurology, Ophthalmology, and Others), By End-Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others) - Trends, Analysis and Forecast till 2034

U.S Imaging CRO Market Size was valued at 2.40 billion in 2024 and is projected to grow at a CAGR of 7.00% to reach US$ 4.77 billion by 2034

The U.S. Imaging Contract Research Organization (CRO) market comprises specialized service providers that assist pharmaceutical, biotechnology, and medical device companies in conducting imaging-related research activities. These services are crucial during the preclinical and clinical phases, offering advanced imaging analysis and data management to enhance the understanding of drug mechanisms and therapeutic efficacy. The market is experiencing significant growth due to the increasing complexity of clinical trials and the high demand for sophisticated imaging technologies to improve diagnostic and therapeutic outcomes.

Key Drivers of Target Market:

Advanced Imaging Technologies

The U.S. is a leader in developing and adopting cutting-edge imaging technologies. Innovations in high-resolution MRI, CT scans, and PET scans have significantly improved the ability to visualize and assess drug efficacy and disease progression. These technologies provide detailed and accurate data essential for the successful development of new therapeutics. The intense focus on research and substantial investments in healthcare technology drive these advancements.

Increasing Outsourcing of Imaging Services

Pharmaceutical and biotechnology companies in the U.S. are increasingly outsourcing their imaging needs to CROs. This trend is driven by the high costs and specialized expertise required for conducting advanced imaging studies. Outsourcing allows companies to leverage the latest imaging technologies and highly skilled professionals without significant capital investment to maintain these capabilities in-house. This approach helps streamline R&D activities and enables companies to focus on their core competencies while benefiting from the expertise and technology provided by CROs.

Restrains:

Complex Regulatory Landscape

The imaging CRO market in the U.S. faces significant challenges due to stringent regulatory requirements imposed by agencies such as the FDA. These regulations ensure the safety and accuracy of imaging procedures used in clinical trials. Compliance can be costly and time-consuming, posing a considerable challenge for CROs. Non-compliance can result in severe penalties, further complicating the operational landscape for these organizations. The stringent regulatory environment can slow the development and approval processes for new drugs and medical devices, creating substantial hurdles for the imaging CRO market.

The market is segmented based on Services Offered, Imaging Modality, Application, and End-Users.

U.S Imaging CRO Market Report Scope:

Attribute	Details
Market Size 2024	US$ 2.40 billion
Projected Market Size 2034	US$ 4.77 billion
CAGR Growth Rate	7.00%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Services Offered - Image Collection & Quality Control, Imaging Acquisition & Protocol Development, Digital Image Conversion, Application Design, Support & Maintenance, and Others By Imaging Modality - Magnetic Resonance Imaging, Computed Tomography Scan, Positron Emission Tomography, and Others By Application - Oncology, Cardiovascular, Neurology, Ophthalmology, and Others By End User - Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Medical Device Manufacturers, and Others
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2023 to 2034. For the purpose of this study segmented the Imaging CRO Market report based on Services Offered, Imaging Modality, Application, End User and Country:

Segmentation:

By Services Offered:

• Image Collection & Quality Control
•  Imaging Acquisition & Protocol Development
•  Digital Image Conversion
• Application Design
• Support & Maintenance
• Others

By Imaging Modality:

• Magnetic Resonance Imaging
• Computed Tomography Scan
• Positron Emission Tomography
• Others

By Application:

• Oncology
• Cardiovascular
• Neurology
• Ophthalmology
• Others

By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Medical Device Manufacturers
• Others

The key players operating the Imaging CRO Market includes IQVIA, PAREXEL, PRA HEALTH SCIENCES, ICON, Syneos Health, Labcorp Drug Development, PPD, Fisher Clinical Services

• IQVIA, Inc. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• PAREXEL
• PRA HEALTH SCIENCES  
• ICON
• Syneos Health, Ltd.
• Labcorp Drug Development  
• PPD, INC.
• Fisher Clinical Services    

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Preview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Services Offered
     • Market Snippet, By Imaging Modality
     • Market Snippet, By Application
     • Market Snippet, By End User
     • Market Snippet, By Country
   • Opportunity Map Analysis
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Market Trends
   • Product Launch
   • Merger and Acquisitions
   • Impact Analysis
   • PEST Analysis
   • Porter’s Analysis

Market Segmentation, By Services Offered, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Image Collection & Quality Control
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Imaging Acquisition & Protocol Development
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Digital Image Conversion
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

• Application Design
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Support & Maintenance
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Imaging Modality, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Magnetic Resonance Imaging
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Computed Tomography Scan
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Positron Emission Tomography
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Application, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cardiovascular
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Neurology
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

• Ophthalmology
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, End User, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Academic & Research Institutions
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Medical Device Manufacturers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

• Others
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Country, Forecast Period Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Country Trends

Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • IQVIA
  • PAREXEL
  • PRA HEALTH SCIENCES  
  • ICON
  • Syneos Health, Ltd.
  • Labcorp Drug Development  
  • PPD, Inc.
  • Fisher Clinical Services          

The Last Word

• Future Impact
• About Us
• Contact